BCLI - BrainStorm Cell Therapeutics GAAP EPS of -$0.14 beats by $0.03
2023-05-15 07:13:08 ET
- BrainStorm Cell Therapeutics press release ( NASDAQ: BCLI ): Q1 GAAP EPS of -$0.14 beats by $0.03 .
- Cash, cash equivalents, and short-term bank deposits were approximately $2.2M as of March 31, 2023, compared to $3 million as of December 31, 2022.
For further details see:
BrainStorm Cell Therapeutics GAAP EPS of -$0.14 beats by $0.03